An Evernorth study found that in 2021, 25% of adults with ADHD did not receive any treatment, though this is a decrease from 38.5% in 2017. About 21.4% of adults with ADHD received both medication and behavioral therapy in 2021, up from 12.9% in 2017.
Neos Therapeutics is planning to make controlled-release ADHD medicines in liquid and dissolving tablet form, so they’re easier for children to take and last throughout the day. The Grand Prairie, Texas, company just rounded up $15.5 million, according to a SEC filing. The company said in a statement that participating investors included Burrill Life Sciences […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.